SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-155618
Filing Date
2018-05-08
Accepted
2018-05-08 12:34:57
Documents
89
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d574491d10q.htm 10-Q 426324
2 EX-10.2 d574491dex102.htm EX-10.2 12937
3 EX-10.3 d574491dex103.htm EX-10.3 13768
4 EX-31.1 d574491dex311.htm EX-31.1 6337
5 EX-31.2 d574491dex312.htm EX-31.2 6323
6 EX-32.1 d574491dex321.htm EX-32.1 6776
13 GRAPHIC g574491g60x80.jpg GRAPHIC 1586
  Complete submission text file 0001193125-18-155618.txt   4454640

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT rgen-20180331.xml EX-101.INS 648244
8 XBRL TAXONOMY EXTENSION SCHEMA rgen-20180331.xsd EX-101.SCH 54611
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgen-20180331_cal.xml EX-101.CAL 83003
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgen-20180331_def.xml EX-101.DEF 407546
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgen-20180331_lab.xml EX-101.LAB 488837
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgen-20180331_pre.xml EX-101.PRE 479049
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-14656 | Film No.: 18813672
SIC: 2836 Biological Products, (No Diagnostic Substances)